NEWS: Patent
ANEW MEDICAL, INC. Strengthens Intellectual Property Protection with U.S. Patent Issuance for Its Secreted RNA Splice Variant of the Human Klotho Gene Used for the Treatment of Neurodegenerative and Age-Related Diseases
ANEW MEDICAL, INC. (NASDAQ: WENA) has been granted U.S. Patent No. 12,036,268 for its secreted RNA splice variant of the human Klotho gene, known as 's-KL'.
This patent strengthens ANEW's intellectual property protection for developing treatments for neurodegenerative and age-related diseases.
The Klotho gene, often called the 'anti-aging' gene, controls various brain and neurologic functions.
ANEW has exclusive worldwide rights to develop and commercialize novel genetic approaches for treating conditions like Alzheimer's, ALS, and Parkinson's disease.
The company's IP portfolio is licensed from Universitat Autònoma de Barcelona and Institució Catalana De Recerca Estudis Avançats. This U.S. patent complements existing patents in Europe, China, and other Asian markets, solidifying ANEW's global IP position.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1444Followers
78Following
11KVisitors
Follow